Orrick represented Ipsen in the transaction. Ipsen, a global biopharmaceutical company with a focus on bringing transformative medicines to patients in oncology, rare diseases and neuroscience,...
Ipsen’s $158 Million Sale of Priority Review Voucher
Neocis’ Financing Round
Orrick Herrington & Sutcliffe LLP advised Mirae Asset Financial Group on the matter. Venture capital funds affiliated with Mirae Asset Financial Group have participated in a...
Ipsen’s Acquisition of Albireo Pharma Inc
Orrick and Cirio advised Ipsen on the deal, while Paul, Weiss, Rifkind, Wharton & Garrison and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Albireo. Ipsen...
Ipsen’s Acquisition of Epizyme
Orrick Herrington & Sutcliffe advised Ipsen on the deal. Global biopharmaceutical company Ipsen (Euronext: IPN; ADR: IPSEY) announced its definitive agreement to acquire Epizyme (Nasdaq: EPZM), a...
Hello Heart’s $70 Million Series D Financing
White & Case advised Hello Heart on the deal while Orrick advised Stripes. Hello Heart, the only digital therapeutic that focuses exclusively on heart health, executed its...
Smash Capital and Insight Partners’ $690 Million Acquisition of Coda Payments
Allen & Gledhill worked closely with its associate firm in Malaysia, Rahmat Lim & Partners, and its network firm in Indonesia, Soemadipradja & Taher, to advise...
Goldman Sachs’ Acquisition of NextCapital
Orrick advised NextCapital on the deal. NextCapital Group announced its acquisition by Goldman Sachs. NextCapital is an open-architecture digital retirement advice provider that partners with financial institutions...
Balto’s $37.5 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Balto on the deal. Morgan Lewis advised Stripes. Balto, the No. 1 real-time guidance platform for contact centers, announced the...